Showing results (1421-1430 of 6,713) with videos related to
Sort By:
Pageof 672
Oncotargets and Therapy|March 10, 2018
CXCR3 is a prognostic marker and a potential target for patients with solid tumors: a meta-analysisYang Zhang, Linjuan Xu, Minggang PengOncotargets and Therapy|March 6, 2018
Characterization of luteinizing hormone-releasing hormone receptor type I (LH-RH-I) as a potential molecular target in OCM-1 and OCM-3 human uveal melanoma cell linesEva Sipos, Nikoletta Dobos, David Rozsa, et al.Oncotargets and Therapy|March 6, 2018
Role of palliative resection of the primary pancreatic neuroendocrine tumor in patients with unresectable metastatic liver disease: a systematic review and meta-analysisBo Zhou, Canyang Zhan, Yuan Ding, et al.Oncotargets and Therapy|August 11, 2015
Determination and validation of mTOR kinase-domain 3D structure by homology modelingWiame Lakhlili, Gwénaël Chevé, Abdelaziz Yasri, et al.Oncotargets and Therapy|December 19, 2013
Intraoperative radiotherapy in stage IIB adenocarcinoma of the uterine cervix: a retrospective studyYing Gao, Zi Liu, Fei Gao, et al.Oncotargets and Therapy|December 19, 2013
Metastatic colorectal cancer first-line treatment with bevacizumab: the impact of K-ras mutationLuigi Rossi, Enzo Veltri, Angelo Zullo, et al.Oncotargets and Therapy|November 23, 2013
B7-H3 is a new cancer-specific endothelial marker in clear cell renal cell carcinomaXiaojian Qin, Hailiang Zhang, Dingwei Ye, et al.Oncotargets and Therapy|May 3, 2018
Role of DiGeorge syndrome critical region gene 9, a long noncoding RNA, in gastric cancerChao Ni, Ping Yang, Junming Guo, et al.Oncotargets and Therapy|May 2, 2018
miR-488 inhibits cell growth and metastasis in renal cell carcinoma by targeting HMGN5Xin Wei, Lili Yu, Xiangbo KongOncotargets and Therapy|May 10, 2018
LDH-Apromotes epithelial-mesenchymal transition by upregulating ZEB2 in intestinal-type gastric cancerYongjie Zhang, Sen Lin, Yan Chen, et al.Pageof 672